OPCH

Option Care Health Inc

OPCH, USA

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

https://www.optioncarehealth.com

Stock Price

$0.00

0%

increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
OPCH
stock
OPCH

Assessing Option Care Health (OPCH) After Expanded Buybacks And 2026 Net Revenue Guidance simplywall.st

Read more →
OPCH
stock
OPCH

Option Care Health (NASDAQ:OPCH) Hits New 52-Week High - Should You Buy? MarketBeat

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$36.4546

Analyst Picks

Strong Buy

6

Buy

3

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

High

25.59

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very High

3.88

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

3.81 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

1.49 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Low

8.43 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

1.56

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 99.90% of the total shares of Option Care Health Inc

1.

BlackRock Inc

(12.6142%)

since

2025/06/30

2.

Vanguard Group Inc

(11.1018%)

since

2025/06/30

3.

Wellington Management Company LLP

(8.2148%)

since

2025/06/30

4.

Durable Capital Partners LP

(5.0757%)

since

2025/06/30

5.

State Street Corp

(3.8089%)

since

2025/06/30

6.

FMR Inc

(3.7826%)

since

2025/06/30

7.

iShares Core S&P Mid-Cap ETF

(3.2841%)

since

2025/08/31

8.

Vanguard Total Stock Mkt Idx Inv

(3.1508%)

since

2025/07/31

9.

Vanguard Health Care Inv

(3.0246%)

since

2025/06/30

10.

Fuller & Thaler Asset Management Inc

(2.835%)

since

2025/06/30

11.

FullerThaler Behavioral Small-Cap Equity

(2.6983%)

since

2025/06/30

12.

FullerThaler Behavioral Sm-Cp Eq R6

(2.6983%)

since

2025/06/30

13.

Geode Capital Management, LLC

(2.5337%)

since

2025/06/30

14.

Vanguard Small Cap Index

(2.4493%)

since

2025/07/31

15.

iShares Russell 2000 ETF

(2.4438%)

since

2025/08/31

16.

Dimensional Fund Advisors, Inc.

(2.1941%)

since

2025/06/30

17.

Arrowstreet Capital Limited Partnership

(2.1014%)

since

2025/06/30

18.

Vanguard Explorer Inv

(1.978%)

since

2025/06/30

19.

Morgan Stanley - Brokerage Accounts

(1.9274%)

since

2025/06/30

20.

Westfield Capital Management Company, L.P.

(1.8864%)

since

2025/06/30

21.

Charles Schwab Investment Management Inc

(1.573%)

since

2025/06/30

22.

Northern Trust Corp

(1.4254%)

since

2025/06/30

23.

Vanguard Small Cap Growth Index Inv

(1.379%)

since

2025/07/31

24.

NORGES BANK

(1.3266%)

since

2025/06/30

25.

Jennison Associates LLC

(1.3175%)

since

2025/06/30

26.

T. Rowe Price Associates, Inc.

(1.1844%)

since

2025/06/30

27.

Vanguard Institutional Extnd Mkt Idx Tr

(1.085%)

since

2025/07/31

28.

Manufacturers Life Insurance Co

(1.0516%)

since

2025/06/30

29.

Bank of America Corp

(1.0395%)

since

2025/06/30

30.

Fidelity Small Cap Index

(1.0189%)

since

2025/06/30

31.

Nuveen, LLC

(1.0161%)

since

2025/06/30

32.

iShares Russell 2000 Growth ETF

(0.8924%)

since

2025/08/31

33.

SPDR® S&P MIDCAP 400 ETF Trust

(0.7729%)

since

2025/07/31

34.

Calvert US Small-Cap Strategy

(0.7643%)

since

2025/06/30

35.

Calvert Small-Cap A

(0.7643%)

since

2025/07/31

36.

Fidelity Mid-Cap Stock

(0.7513%)

since

2025/07/31

37.

T. Rowe Price Integrated US Sm Gr Eq

(0.7392%)

since

2025/07/31

38.

T. Rowe Price Integrated US SmCapGrEq

(0.7392%)

since

2025/06/30

39.

Jennison SMid Cap Core Equity

(0.6291%)

since

2025/06/30

40.

FIAM Small Cap Core CIT Cl B

(0.6232%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.462

Latest Release

Date

2025-09-30

EPS Actual

0.45

EPS Estimate

0.43

EPS Difference

0.02

Surprise Percent

4.6512%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(6.3)
GARP
Fair GARP(3.5)
Growth
Weak Growth Prospect(3)
Momentum
Moderate Momentum(4.5)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(4)
Value
Fair Value(3.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.